| Literature DB >> 32742764 |
Shanshan Zhu1, Yuhe Zhu1, Zhenbo Wang2, Chen Liang2, Nanjue Cao3, Ming Yan1, Fei Gao1, Jie Liu4, Wei Wang1.
Abstract
BACKGROUND: To analyze and identify the circular RNAs (circRNAs) involved in promoting the osteogenic differentiation of human bone mesenchymal stem cells (hBMSCs) on titanium by surface mechanical attrition treatment (SMAT).Entities:
Keywords: Biological information prediction; Human bone marrow mesenchymal stem cells; Osteogenic differentiation; Surface mechanical attrition treatment; circRNA
Year: 2020 PMID: 32742764 PMCID: PMC7365136 DOI: 10.7717/peerj.9292
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Primer and internal reference gene sequence table.
| Name of circRNA/internal reference | Primer sequence (5′–3′) | Product length (bp) |
|---|---|---|
| hsa_circ_0032599 | CTGGAACCTGCGTGAACCT | 226 |
| TGATCCGCTGGGCCAAAG | ||
| hsa_circ_0032600 | CTGGAACCTGCGTGAACCT | 221 |
| TCTTGGCAGTGAGTGAGGTT | ||
| hsa_circ_0032601 | CTGGAACCTGCGTGAACCT | 229 |
| TGGTGGATCTGCACTGAGG | ||
| GAPDH | GGACCTGACCTGCCGTCTAG | 99 |
| TAGCCCAGGATGCCCTTGAG |
Figure 1The TEM observation of the gradient nano-metal pure titanium.
Figure 2Culture and proliferation curve of the hBMSCs.
(A) HBMSCs cultured for 1 day (×100). (B) HBMSCs cultured for 3 days (×100). (C) CCK8 detection at 1, 3, 5, and 7 days of hBMSCs culture. *The SMAT group compared with the annealed group (mean ± SD, n = 3, *indicates p < 0.05).
Figure 3Detection of ALP activity and alizarin red staining of hBMSCs.
(A) Detection of ALP activity at 3, 5, 7 and 14 days after osteogenic induction of hBMSCs. *The SMAT group compared with the annealed group (mean ± SD, n = 3, *indicates p < 0.05). (B) Alizarin red staining after osteogenic induction of hBMSCs for 7, 14 and 21 days. (C) The area of alizarin red staining at 7, 14, 21 days after osteogenic induction of hBMSCs. *The SMAT group compared with the annealed group (mean ± SD, n = 3, *indicates p < 0.05).
Figure 4Biological information prediction.
(A) Numbers of circRNAs corresponding to different chrs. (B) Numbers of circRNAs on different signaling pathways. (C) WNT3, WNT4 genes in Wnt signaling pathway. (D) WNT8B gene in Wnt signaling pathway. (E) RUNX2 gene in Notch signaling pathway. (F) CBFB gene in Smad2/3 signaling pathway. (G) LIF gene in ERK signaling pathway. (H) IGF1 gene in MAPK/ERK signaling pathway. (I) INHBC, ACVR1B genes in TGF-βsignaling pathway. (J) NOG gene in TGF-βsignaling pathway. (K) CHRD gene in TGF-β signaling pathway. (L) BMP7 gene in TGF-β, ERK signaling pathways. (M) Network analysis of osteogenesis-related miRNAs and their interacting circRNAs and target genes.
Predicted miRNAs and their gene symbols and signaling pathways.
| miRNA | Gene symbol | Signaling pathway |
|---|---|---|
| hsa-miR-18b-5p | ABCA3 | |
| hsa-let-7b-5p | HERC1 | |
| hsa-miR-1224-5p | MCF2L2, PLPPR4, SPEG | |
| hsa-miR-129-5p | FAT3, LTBP2, MYH9, SMARCA2, TBC1D2B, VPS13C, DYNC1H1 | |
| DGKD | Phospholipase D, Gastrin-CREB via PKC and MAPK | |
| hsa-miR-145-5p | BRPF3, TANGO6 | |
| COL4A2 | AGE-RAGE, ERK, FAK1, GnRH, ILK | |
| hsa-miR-24-3p | ADAMTS13, DIP2C, SYNM | |
| hsa-miR-5195-3p | ARHGAP32, CCDC88C, FLNA, LTBP2, MDN1, RAB31, TBCD, TRIOBP | |
| GNB5 | Corticotropin-releasing hormone, G Protein, Apelin, Chemokine, Chemotaxis CXCR4 | |
| hsa-miR-6088 | CARD8 | NOD-like receptor |
| KMT2A | ||
| hsa-miR-18b-5p | ABCA3 | |
| hsa-let-7b-5p | HERC1 | |
| hsa-miR-1224-5p | MCF2L2, PLPPR4, SPEG | |
| hsa-miR-129-5p | FAT3, LTBP2, MYH9, SMARCA2, TBC1D2B, VPS13C, DYNC1H1 | |
| DGKD | Phospholipase D, Gastrin-CREB via PKC and MAPK | |
| hsa-miR-145-5p | BRPF3, TANGO6 | |
| COL4A2 | AGE-RAGE, ERK, FAK1, GnRH, ILK | |
| hsa-miR-24-3p | ADAMTS13, DIP2C, SYNM | |
| hsa-miR-5195-3p | ARHGAP32, CCDC88C, FLNA, LTBP2, MDN1, RAB31, TBCD, TRIOBP | |
| GNB5 | Corticotropin-releasing hormone, G Protein, Apelin, Chemokine, Chemotaxis CXCR4 | |
| hsa-miR-6088 | CARD8 | NOD-like receptor |
| KMT2A |
Predicted circRNAs and their chrs, gene symbols, miRNAs, and signaling pathways.
| chr | hsa_circRNA | Gene symbol | miRMA | Signaling pathway |
|---|---|---|---|---|
| chr10 | hsa_circ_0076184 | BRPF3 | hsa-miR-129-5p | |
| hsa_circ_0002749 | CARD8 | hsa-miR-129-5p | NOD-like receptor | |
| chr13 | hsa_circ_0051734 | CARD8 | hsa-miR-129-5p | NOD-like receptor |
| chr | hsa_circRNA | Gene symbol | miRMA | Signaling pathway |
| chr14 | hsa_circ_005173 | CARD8 | hsa-miR-129-5p | NOD-like receptor |
| hsa_circ_0051736 | ||||
| hsa_circ_0030878 | COL4A2 | hsa-miR-129-5p | AGE-RAGE, ERK, FAK1, GnRH, ILK | |
| hsa_circ_0058776 | DGKD | hsa-miR-129-5p | Phospholipase D, Gastrin-CREB viaPKC and MAPK | |
| hsa_circ_0017364 | DIP2C | hsa-miR-129-5p | ||
| hsa_circ_0017365 | ||||
| hsa_circ_0091990 | ||||
| hsa_circ_0091991 | ||||
| hsa_circ_0091992 | FLNA | hsa-miR-145-5p | ||
| hsa_circ_0091997 | ||||
| hsa_circ_0091998 | ||||
| hsa_circ_0091999 | ||||
| hsa_circ_0092000 | ||||
| hsa_circ_0092001 | ||||
| chr15 | hsa_circ_0092008 | FLNA | hsa-miR-145-5p | |
| hsa_circ_0092009 | ||||
| hsa_circ_0092010 | ||||
| hsa_circ_0035311 | GNB5 | hsa-miR-24-3p | Corticotropin-releasing hormone, G Protein, Apelin, Chemokine, Chemotaxis CXCR4 | |
| hsa_circ_0035312 | ||||
| hsa_circ_0035313 | ||||
| hsa_circ_0032566 | LTBP2 | hsa-miR-24-3p | ||
| hsa_circ_0032576 | ||||
| hsa_circ_0032579 | ||||
| hsa_circ_0032584 | ||||
| hsa_circ_0032585 | ||||
| hsa_circ_0032594 | ||||
| chr17 | hsa_circ_0032599 | |||
| hsa_circ_0032600 | LTBP2 | hsa-miR-24-3p | ||
| hsa_circ_0032601 | ||||
| hsa_circ_0032602 | ||||
| hsa_circ_0032604 | ||||
| hsa_circ_0032605 | ||||
| hsa_circ_0032607 | ||||
| hsa_circ_0032608 | ||||
| chr17 | hsa_circ_0077356 | MDN1 | hsa-miR-5195-3p | |
| hsa_circ_0077360 | ||||
| hsa_circ_0077371 | ||||
| chr18 | hsa_circ_0077375 | MDN1 | hsa-miR-5195-3p | |
| hsa_circ_0063112 | MYH9 | hsa-miR-5195-3p | ||
| chr19 | hsa_circ_0063114 | MYH9 | hsa-miR-5195-3p | |
| hsa_circ_0063115 | ||||
| hsa_circ_0063117 | ||||
| hsa_circ_0046890 | RAB31 | |||
| chr2 | hsa_circ_0046891 | RAB31 | ||
| chr22 | hsa_circ_0037043 | SYNM | hsa-miR-5195-3p | |
| hsa_circ_0036435 | TBC1D2B | hsa-miR-6088 | ||
| hsa_circ_0036436 | ||||
| hsa_circ_0036437 | ||||
| chr6 | hsa_circ_0036438 | TBC1D2B | hsa-miR-6088 | |
| hsa_circ_0036439 | ||||
| hsa_circ_0036440 | ||||
| hsa_circ_0036441 | ||||
| hsa_circ_0046529 | TBCD | hsa-miR-6088 | ||
| Chrx | hsa_circ_0046568 | TBCD | hsa-miR-6088 | |
| hsa_circ_0046569 | ||||
| hsa_circ_0046577 | ||||
| hsa_circ_0046588 | ||||
| hsa_circ_0046589 | ||||
| hsa_circ_0046590 | ||||
| hsa_circ_0046591 | ||||
| hsa_circ_0046594 | ||||
| hsa_circ_0046595 | ||||
| hsa_circ_0046596 | ||||
| hsa_circ_0035596 | VPS13C | hsa-miR-6088 |
Figure 5QRT-PCR results of the three differentially expressed circRNAs.
*The SMAT group compared with the annealed group, FC > 2.0 (mean ± SD, n = 3, *indicates p < 0.05).